SEC Company Response from TuHURA Biosciences, (HURA) — Jul 2, 2015
TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382)
Date: July 2, 2015 · CIK: 0001498382 · Accession: 0001013762-15-000678
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-203357
Letter
Re: DelMar Pharmaceuticals, Inc. (the “Company”)
July 2,
Securities and Exchange Commission
100 F. Street, NE
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-203357
Ladies and Gentlemen:
Reference is made to our letter, filed as correspondence via EDGAR on July 1, 2015, in which we, Maxim Group LLC and Roth Capital Partners, LLC, as co-lead placement agents of the Company’s proposed offering, joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for Thursday, July 2, 2015, at 1:00 p.m. Eastern Time. The Company Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
Very truly
yours,
MAXIM
GROUP LLC
Show Raw Text
CORRESP 1 filename1.htm July 2, 2015 Securities and Exchange Commission 100 F. Street, NE Washington, D.C. 20549 Re: DelMar Pharmaceuticals, Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-203357 Ladies and Gentlemen: Reference is made to our letter, filed as correspondence via EDGAR on July 1, 2015, in which we, Maxim Group LLC and Roth Capital Partners, LLC, as co-lead placement agents of the Company’s proposed offering, joined the Company’s request for acceleration of the effective date of the above-referenced Registration Statement for Thursday, July 2, 2015, at 1:00 p.m. Eastern Time. The Company Inc. is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date. Very truly yours, MAXIM GROUP LLC By: /s/ Clifford Teller Name: Clifford Teller, Executive Managing Director, Head of Investment Banking ROTH CAPITAL PARTNERS, LLC By: /s/ Aaron M. Gurewitz Name: Aaron M. Gurewitz Head of Equity Capital Markets